2014 FDA drug approvals

被引：93

作者：

Mullard, Asher

机构：

来源：

关键词：

D O I：

10.1038/nrd4545

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

The FDA approved 41 new therapeutics in 2014, but the bumper year fell short of the commercial power of the drugs approved in 2013.

引用

页码：77 / 81

页数：5

共 50 条

[1] 2014 FDA drug approvals
Asher Mullard
Nature Reviews Drug Discovery, 2015, 14 : 77 - 81
[2] US FDA oncology drug approvals in 2014
Wolford, Juliet E.
Tewari, Krishnansu S.
FUTURE ONCOLOGY, 2015, 11 (13) : 1931 - 1945
[3] 2015 FDA drug approvals
Asher Mullard
Nature Reviews Drug Discovery, 2016, 15 : 73 - 76
[4] 2016 FDA drug approvals
Mullard, Asher
NATURE REVIEWS DRUG DISCOVERY, 2017, 16 (02) : 73 - 76
[5] 2013 FDA drug approvals
Asher Mullard
Nature Reviews Drug Discovery, 2014, 13 : 85 - 89
[6] Recent FDA drug approvals
Naccari, Christopher
CNS SPECTRUMS, 2008, 13 (06) : 466 - 466
[7] 2011 FDA drug approvals
Asher Mullard
Nature Reviews Drug Discovery, 2012, 11 (2) : 91 - 94
[8] 2008 FDA drug approvals
Hughes, Bethan
NATURE REVIEWS DRUG DISCOVERY, 2009, 8 (02) : 93 - 96
[9] 2008 FDA drug approvals
Bethan Hughes
Nature Reviews Drug Discovery, 2009, 8 : 93 - 96
[10] 2018 FDA drug approvals
Mullard, Asher
NATURE REVIEWS DRUG DISCOVERY, 2019, 18 (02) : 85 - 89